Over the past decade, community action and scientific advancement have helped transform the global response to HIV. With the emergence of pre-exposure prophylaxis (PrEP) and the promotion of Undetectable=Untransmittable (U=U), the world has recognized that ending the HIV epidemic is a realistic and achievable goal. However, the COVID-19 pandemic has challenged everyone in difficult and unexpected ways, threatening to divert focus from HIV and jeopardize hard-won progress toward ending the HIV epidemic.
Gilead believes that people should have access to the same quality of healthcare, regardless of their background and circumstances. Through the Zeroing In™: Ending the HIV Epidemic program, we aim to build on previous efforts to support organizations working to improve the overall health and wellness of communities most impacted by the HIV epidemic and the COVID-19 pandemic.
We welcome you to learn more about the many Zeroing In supported programs and partners striving to help end the HIV epidemic for everyone, everywhere.